ノルウェー - ノルウェー語 - Statens legemiddelverk

orifarm as - simvastatin - tablett, filmdrasjert - 40 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

orifarm as - simvastatin - tablett, filmdrasjert - 40 mg

欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - mogamulizumab - sezary syndrome; mycosis fungoides - antineoplastiske midler - poteligeo er indisert for behandling av voksne pasienter med mycosis fungoides (mf) eller sézary syndrom (ss) som har mottatt minst én tidligere systemisk terapi.

ノルウェー - ノルウェー語 - Statens legemiddelverk

orifarm as - ezetimib / simvastatin - tablett - 10 mg / 20 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

orifarm as - ezetimib / simvastatin - tablett - 10 mg / 40 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

orifarm as - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

2care4 aps - ezetimib / simvastatin - tablett - 10 mg / 20 mg

ノルウェー - ノルウェー語 - Statens legemiddelverk

abacus medicine a/s - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg

欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidin - leukemi, myeloid, akutt - antineoplastiske midler - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

ノルウェー - ノルウェー語 - Statens legemiddelverk

accord healthcare b.v. - ezetimib / simvastatin - tablett - 10 mg / 20 mg